200 related articles for article (PubMed ID: 19410518)
1. New insights into the pathophysiology of idiopathic nephrotic syndrome.
Bruneau S; Dantal J
Clin Immunol; 2009 Oct; 133(1):13-21. PubMed ID: 19410518
[TBL] [Abstract][Full Text] [Related]
2. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
3. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S
Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031
[TBL] [Abstract][Full Text] [Related]
4. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
Salomon R; Gagnadoux MF; Niaudet P
Transplantation; 2003 Mar; 75(6):810-4. PubMed ID: 12660507
[TBL] [Abstract][Full Text] [Related]
5. [Successful correction of post-transplantation nephrotic syndrome with mabtera].
Goriaĭnov VA; Kaabak MM; Babenko NN; Zokoev AK; Morozova MM; Shishlo LA
Ter Arkh; 2009; 81(12):34-6. PubMed ID: 20481046
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
7. Effects of plasma-protein A immunoadsorption on idiopathic nephrotic syndrome recurring after renal transplantation.
Dantal J; Testa A; Bigot E; Soulillou JP
Ann Med Interne (Paris); 1992; 143 Suppl 1():48-51. PubMed ID: 1300888
[TBL] [Abstract][Full Text] [Related]
8. [Value of cyclosporine in the treatment of the recurrence of nephrosis after renal transplantation].
Ranchin B; Gagnadoux MF; Broyer M; Lehnert A; Juresco A; Chérif N; Jan D; Droz D; Gubler MC; Niaudet P
Nephrologie; 1996; 17(8):441-5. PubMed ID: 9036367
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report.
Sirimongkolrat T; Premasathian N; Vongwiwatana A; Limsrichamrern S; Cheunsuchon B; Vasuvattakul S
Transplant Proc; 2008 Sep; 40(7):2440-1. PubMed ID: 18790261
[TBL] [Abstract][Full Text] [Related]
10. Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type.
Chaudhuri A; Kambham N; Sutherland S; Grimm P; Alexander S; Concepcion W; Sarwal M; Wong C
Pediatr Transplant; 2012 Aug; 16(5):E183-7. PubMed ID: 21672106
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
12. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
14. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S
Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906
[TBL] [Abstract][Full Text] [Related]
15. Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome.
Bernard J; Bruel A; Allain-Launay E; Dantal J; Roussey G
Pediatr Transplant; 2018 Jun; 22(4):e13175. PubMed ID: 29569812
[TBL] [Abstract][Full Text] [Related]
16. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations.
François H; Daugas E; Bensman A; Ronco P
Am J Kidney Dis; 2007 Jan; 49(1):158-61. PubMed ID: 17185157
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for post-transplant recurrences of FSGS.
Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M
Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
[TBL] [Abstract][Full Text] [Related]
19. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
Hyla-Klekot L; Grenda R; Pulcer B
Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
